320 Hatch Drive
Foster City, CA 94404
United States
415-851-2410
https://www.notablelabs.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 16
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. Thomas A. Bock M.B.A., M.D. | CEO & Director | 508,82k | N/A | 1965 |
Mr. Scott Alan McPherson CFE, CPA, CVA | Chief Financial Officer | 412,89k | N/A | 1961 |
Dr. Joseph P. Wagner Ph.D. | Chief Scientific Officer | 424,88k | N/A | 1968 |
Dr. Glenn C. Michelson M.D. | Chief Medical Officer | N/A | N/A | N/A |
Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California.
Notable Labs, Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.